The peptide market will show incredible performances growing from the actual 30 B$ to the 58 B$ by the year 2026. This jump is directly related to the improvement of the drug design and development process achieved during the last 10 years (1). In fact, not long time ago, once the active peptide was identified, the drug, a peptidomimetic molecule, was obtained after an extensive medicinal chemistry program. Nowadays, with a few modifications of the natural sequence, it is possible to generate analogue peptides with a controlled conformation and an improved pharmaceutical profile, like long halflife and oral delivery.

Peptide Drug Discovery and Process Development Perspectives

Walter Cabri
2022

Abstract

The peptide market will show incredible performances growing from the actual 30 B$ to the 58 B$ by the year 2026. This jump is directly related to the improvement of the drug design and development process achieved during the last 10 years (1). In fact, not long time ago, once the active peptide was identified, the drug, a peptidomimetic molecule, was obtained after an extensive medicinal chemistry program. Nowadays, with a few modifications of the natural sequence, it is possible to generate analogue peptides with a controlled conformation and an improved pharmaceutical profile, like long halflife and oral delivery.
Walter Cabri
File in questo prodotto:
Eventuali allegati, non sono esposti

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/882807
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact